credence research inc n.
Download
Skip this Video
Loading SlideShow in 5 Seconds..
Erythropoietin Drugs Market- Growth, Share, Opportunities, Competitive Analysis, and Forecast 2016 – 2023 PowerPoint Presentation
Download Presentation
Erythropoietin Drugs Market- Growth, Share, Opportunities, Competitive Analysis, and Forecast 2016 – 2023

Loading in 2 Seconds...

play fullscreen
1 / 3

Erythropoietin Drugs Market- Growth, Share, Opportunities, Competitive Analysis, and Forecast 2016 – 2023 - PowerPoint PPT Presentation


  • 5 Views
  • Uploaded on

According to the latest market report published by Credence Research, Inc. “Erythropoietin\nDrugs Market - Growth, Future Prospects, and Competitive Analysis, 2017 -\n2025,” the global erythropoietin drugs market was valued at US$ 9,097.7 Mn in 2016, and is\nexpected to reach US$ 19,653.2 Mn by 2025

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about 'Erythropoietin Drugs Market- Growth, Share, Opportunities, Competitive Analysis, and Forecast 2016 – 2023' - amanj111


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
credence research inc

Credence Research Inc.

“Erythropoietin Drugs Market- Growth, Share, Opportunities, Competitive

Analysis, and Forecast 2016 – 2023”

Buy Now

Sample Request

E-mail: sales@credenceresearch.com

Ph: 1-800-361-8290

Web: http://www.credenceresearch.com

request sample

Request Sample

According to the latest market report published by Credence Research, Inc. “Erythropoietin

Drugs

Market -

Growth,

Future

Prospects,

2025,” the global erythropoietin drugs market was valued at US$ 9,097.7 Mn in 2016, and is

expected to reach US$ 19,653.2 Mn by 2025, expanding at a CAGR of 9% from 2017 to 2025.

Browse the full report Erythropoietin Drugs Market - Growth, Future Prospects and

Competitive

Analysis,

at http://www.credenceresearch.com/report/erythropoietin-drugs-market

Market Insights

According to the Centers for Disease Control and Prevention (CDC), around 5.5 Mn ambulatory

care patients suffer from anemia due to a nutritional deficiency, while chronic disease is the

second most prevalent cause. Even though anemia is a common symptom in chronic disease,

it still goes underdiagnosed and undertreated, especially in chronic kidney disease (CKD)

patients not undergoing dialysis anemia is undertreated. In U.S., around 20 Mn people suffer

from CKD, out of which 2-4 million have anemia. Anemia increases substantial economic

burden and also affects quality of life. Rising incidence of CKD, cancer and HIV is the major

factor fuelling the demand of erythropoietin drugs. Advancement in recombinant DNA

technology has led to introduction of different forms of drugs such as epoetin-beta,

darbepoetin-alfa and others. Biologics currently dominate the erythropoietin drugs market; but

the entry of novel drugs with biosimilar formulations with better efficacy and cost effectiveness

would present lucrative opportunities. Biosimilars would be a fast growing market, especially

in developing countries in Asia Pacific and Middle East & Africa, due to low cost therapeutics

and enhanced efficacy.

The global erythropoietin drugs market is segmented by drug type into epoetin-alfa, epoetin-

beta, darbepoetin-alfa and others. Epoetin-alfa dominates the global erythropoietin drugs

market, since it is the first biologic for anemia caused due to kidney disease, cancer or HIV

and is widely accepted by physicians. The global erythropoietin drugs market is segmented by

application type into anemia (cancer and HIV), kidney disorders (ESRD and dialysis) and

others (neural diseases, wound healing and others). Renal disease occupies a large share of

the market due to the reported increase in prevalence of kidney disorders.

As of the current market scenario, North America dominated the global erythropoietin drugs

market followed by the European market. Rising prevalence of renal disease, cancer and HIV,

well established research and healthcare infrastructure, favorable reimbursement policies are

the key factors driving the North American market. Additionally, major biopharmaceutical.....

and

Competitive

Analysis,

2017

-

2017

2025

request sample 1

Request Sample

Browse the full Erythropoietin Drugs Market - Growth, Future Prospects and Competitive Analysis,

2017 – 2025 report at http://www.credenceresearch.com/report/erythropoietin-drugs-market

Latest Reports:

http://www.credenceresearch.com/report/tonic-wine-market

http://www.credenceresearch.com/report/digital-diagnostics-market

About:

Credence Research is a worldwide market research and counseling firm that serves driving organizations,

governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with

making enduring enhancements to their execution and understand their most imperative objectives. Over almost

a century, we've manufactured a firm extraordinarily prepared for this task.

Media Contact

Name: Chris Smith

Address: 105 N 1st ST #429,

SAN JOSE, CA 95103 US

E-mail: sales@credenceresearch.com

Ph: 1-800-361-8290

Web: http://www.credenceresearch.com